Research Linking Ozempic to Blindness Research continues to emerge regarding serious side effects of Ozempic and other GLP-1 receptor agonists: January 2026: Patients Who Experienced Vision Loss After Ozempic Can Make Their Case in Federal Court In December of 2025, the Joint Panel on Multidistrict Litigation chose to centralize lawsuits filed by people who took GLP-1 drugs and then were diagnosed with NAION
While these medications typically reduce blood pressure modestlya benefit for many patientssome individuals may experience low blood pressure (hypotension) or related symptoms like dizziness and lightheadedness
Regular blood work becomes essential when combining semaglutide with multiple medications, particularly those affecting blood sugar, thyroid function, or kidney function
Lifting weights, going to Pilates, and doing squats, pushups, and walking lunges all count
Researchers have observed the drugs impact on diseases other than diabetes and obesity in clinical trials and among people taking the medications in real-world settings
